Malik Kemal 4
4 · Cartesian Therapeutics, Inc. · Filed Jan 6, 2025
Insider Transaction Report
Form 4
Malik Kemal
Director
Transactions
- Award
Common Stock
2025-01-02+2,600→ 8,533 total - Award
Stock Option (Right to Buy)
2025-01-02+7,800→ 7,800 totalExercise: $16.93From: 2026-01-02Exp: 2035-01-01→ Common Stock (7,800 underlying)
Footnotes (1)
- [F1]Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest in full on January 2, 2026.